Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer

ISSN： 1745-5057

Source： Women's Health, Vol.2, Iss.1, 2006-01, pp. : 89-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women

By Mouridsen Henning T.

Current Medical Research and Opinion, Vol. 22, Iss. 8, 2006-08 ,pp. : 1609-1621

Informa Healthcare

Access to resources Recommend Favorite

Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer

By Buzdar Aman Chlebowski Rowan Cuzick Jack Duffy Sean Forbes John Jonat Walter Ravdin Peter

Current Medical Research and Opinion, Vol. 22, Iss. 8, 2006-08 ,pp. : 1575-1585

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant endocrine therapy for postmenopausal women with early stage breast cancer

By Grant Margaret Rea Daniel W

Therapy, Vol. 1, Iss. 2, 2004-11 ,pp. : 305-318

Future Medicine

Access to resources Recommend Favorite

Safety Considerations of Adjuvant Therapy in Early Breast Cancer in Postmenopausal Women

Oncology, Vol. 69, Iss. 1, 2005-09 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

The evolving role of adjuvant radiotherapy for elderly women with early‐stage breast cancer

CANCER, Vol. 121, Iss. 14, 2015-07 ,pp. : 2331-2340

John Wiley & Sons Inc

Access to resources Recommend Favorite